NP / PA
Friedlander, Geoffrey
Friedlander, Geoffrey was paid $58K by Medicaid between Jan 2019 and Sep 2021, across 6 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 44% of everything it billed.
33Billing provider infoFRIEDLANDER, GEOFFREY
CORNWALL, NY 12518
CORNWALL, NY 12518
33aNPI1699162255assigned 04/22/2015
33bProvider typePsychiatric/Mental Health Nurse Practitioner
28Total paid$58K
24GClaims521
24DCodes billed6
24AFirst – last monthJan 2019 – Sep 2021
Compared with peers
Next to other Psychiatric/Mental Health Nurse Practitioner providers in New York
Rank by total paid#75 of 328
Median peer was paid$7K
This provider vs. median7.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 135 | $17K | |
| 2020 | 310 | $31K | |
| 2021 | 76 | $10K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44% | 261 | 259 | $26K |
| S9083 | Global fee urgent care centers | 38% | 148 | 147 | $22K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.6% | 40 | 39 | $4K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 5.6% | 25 | 25 | $3K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.6% | 28 | 28 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 19 | 19 | $974.89 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.